UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 87 filers reported holding UROGEN PHARMA LTD in Q2 2023. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,895 | +163.3% | 1,206 | +94.5% | 0.00% | – |
| Q2 2023 | $6,417 | +12.0% | 620 | 0.0% | 0.00% | – |
| Q1 2023 | $5,729 | +14.6% | 620 | -3.1% | 0.00% | – |
| Q4 2022 | $5,000 | 0.0% | 640 | +3.2% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 620 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | +25.0% | 620 | +24.0% | 0.00% | – |
| Q1 2022 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |